All In MedTech

Device Trial Radar · NCT00286195

Frontier Registry II Bifurcation Stent System Registry

The Abbott Vascular MULTI -LINK FRONTIER Coronary Bifurcation Stent System Registry II

Last checked: Nov 20, 2026Latest source record: May 13, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Dec 2004

Primary completion

Dec 2006

Study completion Dec 2006

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Feb 3, 2006

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To assess the procedural success, performance, 30-day and 6 month clinical outcome of bifurcation stenting, and the six month incidence of clinically indicated target lesion revascularization with the use of the Abbott Vascular MULTI-LINK FRONTIER Coronary Bifurcation Stent System in patients with de novo or restenotic bifurcation lesions.

Conditions

  • Coronary Artery Disease

Interventions

  • Multi-Link Frontier Coronary Stent SystemDevice

    Bare metal stent

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Major Adverse Cardiac Events (MACE): Death, Q-wave and non-Q wave Myocardial Infarction, Target Lesion Revascularization (main branch and side branch) including PTCA and CABG at 6 months (180 days).Time frame: 180 days and one year
  2. Acute ischemic, hemorrhagic and vascular complications.Time frame: one year
  3. Target Vessel Failure (TVF) rate (Death, Q-wave and non-Q-wave Myocardial Infarction and Target Vessel Revascularization (TVR) including PTCA and CABG at one month (30 days) and six months (180 days) follow up.Time frame: 6 months

1 more outcomes with a free account

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.